Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lindsay

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Plos One|September 13, 2014
A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in miceSvetlana Rabinovich, Rebecca L R Powell, Ross W B Lindsay, et al.
The Lancet. Oncology|July 28, 2022
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupHolly B Lindsay, Maura Massimino, Shivaram Avula, et al.
The Journal of Clinical Investigation|February 3, 2015
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signalingKylie M Quinn, Daniel E Zak, Andreia Costa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Neuro-Oncology|June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Plos One|September 13, 2014
A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in miceSvetlana Rabinovich, Rebecca L R Powell, Ross W B Lindsay, et al.
The Lancet. Oncology|July 28, 2022
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupHolly B Lindsay, Maura Massimino, Shivaram Avula, et al.
The Journal of Clinical Investigation|February 3, 2015
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signalingKylie M Quinn, Daniel E Zak, Andreia Costa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2013
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunizationKylie M Quinn, Andreia Da Costa, Ayako Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Neuro-Oncology|June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 13